Lorillard
Acute Effect of Passive Smoking on Lung Function and Airway Responsiveness in Asthmatic Children
Fields
- Author
- Jorres, R.
- Magnussen, H.
- Oldigs, M.
- Magnussen, H.
- Type
- SCRT, SCIENTIFIC REPORT
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART/GRAPH/MAPS
- ABST, ABSTRACT
- Alias
- 87654691/87654722
- Area
- SPEARS,ALEXANDER/EXEC CONF ROOM STORAGE
- Named Organization
- Analytisch Biologisches Forschungslabor
- Digital Equipment
- Forschungsgesellschaft Rauchen Und Gesun
- Gca Environmental Instruments
- Linde Ag
- Monitor Lab
- Sigma Chemie
- Allergopharma
- Digital Equipment
- Named Person
- Adlkofer, F.
- Boerger, S.
- Breslin
- Chai
- Conze, C.
- Dahms
- Jaeger, E.
- Knight
- Magnussen, H.
- Scherer, G.
- Shephard
- Stankus
- Templin, K.
- Wiedemann
- Boerger, S.
- Date Loaded
- 05 Jun 1998
- Request
- R1-004
- R1-048
- R1-132
- R1-048
- Master ID
- 87653565/6821
Related Documents:- 87653565
- 87653567
- 87653568 Washington Legal Foundation Represents Bipartisan Congressional Group Before Epa
- 87653569-3583 Comments of the Washington Legal Foundation, and U.S. Representatives Walter Jones, Steve Neal, Howard Coble, Bill Hefner, Butler Derrick, Robin Tallon, Charles Hatcher, Tom Bliley, John Tanner, Alex Mcmillan, Bart Gordon and Hal Rogers Concerning the Environmental Protection Agency's Draft 'guide to Workplace Smoking Policies'
- 87653584-3661 Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87653662-3937 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87653938-3939 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of the Tobacco Industry
- 87653941-3999 United States Environmental Protection Agency Comments of the Tobacco Institute on Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Review Draft
- 87654000-4002 Exhibit A Environmental Tobacco Smoke: A Handbook for Assessment, Mitigation, and Prevention of Exposures
- 87654004-4100 Comments of R.J. Reynolds Tobacco Company on Health Effects of Passive Smoking - Assessment of Lung Cancer in Adults and Respiratory Disorders in Children ( Epa/600/6-90/0064 - External Review Draft)
- 87654101-4139 A Statistical Review of the Epa Report: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children (Epa/600/6-90/00064 - External Review Draft)
- 87654140-4165 RJR Appendix B Comments of the R.J. Reynolds Tobacco Company on Appendix C to the Health Assessment - Dosimetry of Environmental Tobacco Smoke
- 87654166-4174 RJR Appendix C Comments of the R.J. Reynolds Tobacco Company on Appendix D to the Health Assessment - Alternative Approaches for Estimating the Yearly Number of Lung Cancer Deaths in Nonsmokers Due to Ets Based on Dose Response Modeling
- 87654175-4289 the Epa Review Draft: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87654290-4312 the Epa Review Draft: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87654313-4314 United States Environmental Protection Agency Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies Public Review Draft Comments of the Tobacco Industry
- 87654315 A
- 87654316-4386 United States Environmental Protection Agency Comments of the Tobacco Institute on Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87654387-4406 Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Tobacco Institute Substitute Text)
- 87654408-4418 Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies U.S. E.P.A. Public Review Draft Comments of Phillip Morris Inc.
- 87654419 C
- 87654420-4485 Before the United States Environmental Protection Agency Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies Epa/400/6-90/004 Response of R.J. Reynolds Tobacco Company
- 87654489-4496 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Differences Between Mainstream and Sidestream Smoke
- 87654497-4502 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1 : What Is Ets? Table (Page 10): 'toxic and Cancer Causing Agents in Mainstream and Sidestream Cigarette Smoke' Topic: Nitrosoamines
- 87654503-4514 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Chapter 2: Measuring Ets in the Air and Body Section: Assessing Ets Exposure Section: Biomarker Studies
- 87654515-4531 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa /400/6-90/004 5: Reducing Exposure to Ets
- 87654532-4540 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Chapter 1: What Is Ets? Section: Hazardous Constituents in Ets
- 87654541-4547 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Differences Between Mainstream and Sidestream Smoke Section: Chemical Make-Up Section: Other Contaminants
- 87654548-4572 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 2: Measuring Ets in the Air and Body Section: Other Surrogates Topic: Benzene
- 87654573-4578 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Toxins and Irritants Chapter 3: Health Effects of Ets Section: Irritation
- 87654579-4589 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Toxins and Irritants Topic: Hcn
- 87654592-4603 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Toxins and Irritants Topic: Carbon Monoxide (Co) Chapter 3: Health Effects of Ets Section: People with Heart Disease Section: Heart Disease Section: Respiratory Disease
- 87654604-4612 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Section: Measuring Ets in the Air and Body Topic: Diffusion
- 87654613-4618 Comments on Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Chapter 1: What Is Ets? Toxins and Irritants Carbon Monoxide (Co)
- 87654619-4645 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 2: Measuring Ets in the Air and Body Section: Assessing Ets Exposure Section: Air Monitoring Studies
- 87654646-4652 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 1: What Is Ets? Table (Page 10): 'toxic and Cancer Causing Agents in Mainstream and Sidestream Cigarette Smoke'
- 87654653-4658 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 2: Measuring Ets in the Air and Body Section: Mathematical Models
- 87654662-4671 Comments on: Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies (Draft) Epa 400/6-90/004 Response Addressing: Chapter 3: Health Effects of Ets Section: Cancer at Other Sites
- 87654676-4678 Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87654680-4688 Comments on the Draft Epa Document Environmental Tobacco Smoke A Guide to Workplace Smoking Policies
- 87654690
- 87654724-4729 Comments of Jack E. Peterson, P.E., C.I.H., Ph.D. On Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87654731-4751 Critique of the Draft Report Entitled Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87654753-4763 A Critique of the Public Review Draft 'environmental Tobacco Smoke: A Guide to Workplace Smoking Policies' Issued by the Indoor Air Division of the Office of Air and Radiation, U.S. Environmental Protection Agency
- 87654765-4771 Commentary: 'environmental Tobacco Smoke: A Guide to Workplace Smoking Policies,' Epa Public Review Draft
- 87654773-4775
- 87654777-4850 Comments on the Draft Report by the U.S. Environmental Protection Agency 'environmental Tobacco Smoke: A Guide to Workplace Smoking Policies'
- 87654852-4865 Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies: Comments
- 87654866A-4877 Comments by Philip Witorsch, M.D., Facp, Fccp, on Epa Draft Document 'environmental Tobacco Smoke: A Guide to Workplace Smoking Policies'
- 87654878-4880 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of Independent Scientists 901001 Volume I
- 87654882-4909 Non - Epidemiologic Studies on Potential Pulmonary Carcinogen in Environmental Tobacco Smoke: A Critique of the Environmental Protection Agency's Designation of Environmental Tobacco Smoke As A Group A Carcinogen Pulmonary Carcinogens in Ets (900925)
- 87654911-4915 Comments on Epa Review Drafts 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children.' and 'environmental Tobacco Smoke: A Guide to Workplace Smoking Polices'.
- 87654917-4921 Comment on the External Review Draft of Epa's 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87654923-4942 Review of: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children (Review Draft: 900500) Office of Research and Development & Office of Air and Radiation U.S. Environmental Protection Agency
- 87654944-4948 Epa Draft on Environmental Tobacco Smoke E.T.S.
- 87654950-4963 'the Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children,' Review Draft Epa 900500 Statement of John Wesley Clayton, Jr., Ph.D., D.A.T.S.
- 87654965-4988 Comments on the Risk Assessment Portion of the 900500 Epa Draft Report Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87654990-5007 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children A Commentary on Issues Relating to Lung Cancer in the 900000 Epa External Draft Review
- 87654997-5002 Comments on the Possible Relation Between Passive Smoking and Lung Cancer Appendix Number 1
- 87655009-5011 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children' Epa/600/6-90/006a: 900500 Review Draft
- 87655013-5028 Review Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Epa 600/6-90/006a
- 87655030-5032
- 87655033-5036 the Role of Histopathology in the Evaluation of Risk of Lung Cancer From Environmental Tobacco Smoke
- 87655038-5043 Comments on Epa External Review Draft Report, 900517: Health Effects of Passive Smoking: Assessment of Lung Cancer and Respiratory Disorders in Children (Epa / 600/6-90/006a).
- 87655045-5070 Comments on the Review Draft Released by the Environmental Protection Agency Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655072-5080 Critique of Draft Epa Document Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655081-5122 Meta-Analysis in Epidemiology, with Special Reference to Studies of the Association Between Exposure to Environmental Tobacco Smoke and Lung Cancer: A Critique
- 87655127-5132
- 87655134-5140
- 87655142-5162 Assessing Exposures to Environmental Tobacco Smoke As It Pertains to: 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655164-5194 A Comment on 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'. Epa / 600/6-90/006a, 900500
- 87655196-5201 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disease in Children.' A Commentary on Specific Issues Raised in the Epa 900500 External Review Draft
- 87655203-5215 Comments by Alan J. Gross, Ph.D. On Chapters 3 and 4 of the Epa Draft Document: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87655217-5254 Comments in Regard to: Draft Epa Documents Entitled (1) 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children' (2) Environmental Tobacco Smoke: A Guide to Workplace Smoking Policies
- 87655256-5643 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of Independent Scientists 901001 Volume II
- 87655259 22
- 87655260-5321 Comments on the Draft Document Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655322 23
- 87655323-5326
- 87655327-5404 Commentary on Epa Review Draft 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655405 Appendix A Curriculum Vitae of Commentator
- 87655406 Appendix C Health Effects of Involuntary Smoking: Impact on Tobacco Use, Smoking Cessation, and Public Policies. Seminars in Respiratory Medicine 11 (1) : 87-114. 900000
- 87655407-5434 Health Effects of Involuntary Smoking: Impact on Tobacco Use, Smoking Cessation, and Public Policies
- 87655435 Appendix D Physical, Chemical, and Biological Properties of Tobacco, Tobacco Cigarette Smoke, and Other Tobacco Products Seminars in Respiratory Medicine 10 (4): 297-332, 890000
- 87655436-5471 Physical, Chemical, and Biological Properties of Tobacco, Cigarette Smoke, and Other Tobacco Products
- 87655472 Appendix E the Negative Study Problem
- 87655473 A Perspective on Negative Studies
- 87655474-5548 Negative Studies in the Literature: Summary of Selected Discussions of Negative Studies in Medical Publications
- 87655549 24
- 87655550-5616 An Epidemiological Review of the Epa Report: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children (Epa / 600/6-90/00064 - External Review Draft
- 87655617 25
- 87655618-5642 Comments the Epa Review Draft: 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655643
- 87655644-5646 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of Independent Scientists 901001 Volume III
- 87655648-5684 the Role of Confounding Factors in Assessing Epidemiological Evidence on Ets and Risk of Lung Cancer Comments on Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children (Epa/600/6-90/006a)
- 87655686-5711 Comment on Dr.Hirayama's Record Linkage Study of Japanese Adults in 'epidemiological Evidence of Lung Cancer From Ets' Chapter 3 of the Epa Review Draft 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87655713-5750 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disease in Children' A Commentary on Issues Relating to Lung Cancer in the 900500 Epa External Review Draft
- 87655751-5976 A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke (Ets) to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked Text Draft 3
- 87655977-6043 A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke (Ets) to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked Tables Draft 3
- 87656044-6091 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 87656093-6095 United States Environmental Protection Agency Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of Independent Scientists 901001 Volume IV
- 87656097-6104 Comments by George B. Leslie, Frc Path., on 900500 Epa External Review Draft: 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disease in Children'.
- 87656106-6172 Summary of Major Criticisms of Epa's Draft Risk Assessment: Health Effects of Passive Smoking
- 87656174-6178 Comments on Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Epa/6000/6-90-006a 900500 External Review Draft
- 87656180-6200 Commentary 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- 87656202-6228 'comments on Draft Usepa Document Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children' (900928)
- 87656230-6263 A Response to the Epa Review Draft Document Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656265-6288 Evaluation of the Epa Draft Report Health Effects of Passive Smoking: Assessment of Lung Cancer and Respiratory Disorders in Children
- 87656290-6301 Review of Epa Draft Document: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656303-6309 Comments on Document Review Draft Epa/600/6-90/006a Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656311-6318 Statistical Evaluation of the Association Between Environmental Tobacco Smoke (Ets) and Health Risks Comments to the Epa Review Draft: Health Effects of Passive Smoking . . .
- 87656320-6356 Comments on the Epa Draft Report on Health Effects of Passive Smoking: Assessment of Lung Function in Adults and Respiratory Disorders in Children
- 87656358-6366
- 87656368-6397 Submission of Comments on the Draft Epa Report: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656399-6449 Evaluation of A Report by the U.S. Environmental Protection Agency on: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656450-6460 the Confounding of Occupation and Smoking and Its Consequences
- 87656461-6476 Comparison of Risk of Chronic Conditions and Cancer Between Homemakers and Otherwise Employed Women
- 87656481-6483 Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children Public Review Draft Comments of Independent Scientists 901001 Volume V
- 87656485-6492 Comments on the Epa Review Draft Health Effects of Passive Smoking
- 87656494-6574 Review of the Draft Epa Document Entitled 'health Effects of Passive Smoking, Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656576-6661 Executive Summary Lung Cancer and Exposure to Environmental Tobacco Smoke Assessment of Issues Raised in the Review Draft of the Environmental Protection Agency of the United States
- 87656662-6728 Lung Cancer and Exposure to Environmental Tobacco Smoke Appendix 1 Review of Individual Studies
- 87656729 Lung Cancer and Exposure to Environmental Tobacco Smoke Appendix 2 Papers Submitted for Publication - Not to Be Quoted Without Permission
- 87656730-6748 Confounding and Misclassification Effects in Case Control Studies of Lung Cancer Incidence
- 87656749-6768 Dose-Response Relationships in Studies of Lung Cancer and Exposure to Environmental Tobacco Smoke
- 87656769-6781 Age-Adjustments in Passive Smoking Studies
- 87656783-6796 Comments on the Epa Draft Document Entitled 'health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children
- 87656798-6820 Comments on the Draft Environmental Protection Agency Document: 'health Effect of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children'
- Litigation
- Stmn/Produced
- Author (Organization)
- Krankenhaus Grosshansdorf
- Characteristic
- FLGE, GERMAN LANGUAGE
- Site
- G65
- UCSF Legacy ID
- qvr21e00
Document Images
!
ACUTE EFFECT OF PASSIVE SMOIQNG ON LUNG FUNCTION AND
AIRWAY RESPONSIVENESS IN ASTHMATIC CHILDREN &
Maike Oldigs MD, Rudolf Jorres MS, Helgo Magnussen MD
Krankenhaus Grosshansdorf
Zentrum f{ir Pneumologie und Thoraxchirurgie
LVA Freie und Hansestadt Hamburg
Running title: Passive smoking in childhood asthma
Correspondence: Helgo MAGWSSE.'~1
Krankenhaus Grosshansdorf
Wohrendamm 80
2070 Grosshansdorf
FRG m
~
Telephone: FRG 4102 - 601
150 O)
r11
~
, Supported by Forschungsgesellschaft Rauchen und Gesundheit, Hamburg,
FRG. Mr

Oldigs et aL: Acute effect of passive smoking.... 1
I
SUMMARY
In 11 children with bronchial asthma (age range 8-13 yr, 10 boys, I girl) we
studied the effect of an 1 hour exposure at rest during passive cigarette
smoking (20 ppm CO) or Sham. Exposure was performed in an
environmental chamber. Before and immediately after exposure, lung
function and symptom scores were determined. After exposure, a histamine
inhalation challenge was performed to determine the concentrations which
caused a 100% increase in SRaw, PCtOOSRaw, and a 20% fall in FEVt,
PC20FEV1. Mean (SD) SRaw before and after Sham was 8.7 (3.6) and 9.0 (3.2)
cmHZ0*s, mean FEV1 (SD) was 1.97 (0.32) and 1.98 (0.40) 1, respectively. Before
and after cigarette smoking, mean SRaw (SD) was 10.4 (5.3) and 9.4 (3.3)
cmH2O*s, mean FEVl (SD) was 1.95 (0.37) and 1.94 (0.35) 1, respectively.
Geometric mean (SD) PC1ppSRaw and PCZpFEV1 after Sham was 1.39 (3.0) and
0.70 (2.7) mg/ml, after passive smoking 1.65 (2.5) and 0.96 (2.3) mg/ml,
respectively. There was no statistical difference in lung function and PC-
values between Sham and passive cigarette smoking. The main symptoms
during passive smoking were eye and nasopharyngeal irritation.
Our observations suggest that in children with mild bronchial asthma one
hour of passive cigarette smoking does not cause airway obstruction or
changes in bronchial responsiveness.
KEY WORDS:
Passive Smoking, Lung Function, Bronchial Hyperresponsiveness, Childhood
Asthma

Oldigs et aL: Acute effect of passive smoking....2
INTRODUCrlON
Subjects with bronchial asthma are characterized by airway hyper-
responsiveness to a variety of stimuli. Cigarette smoke is considered to be a
common stimulus which may affect subjects with asthma (1-3).
In children, the adverse effect of chronic passive smoking on respiratory
symptoms has received increasing attention (4-7). In some of these
investigations an association between parental smoking habits and acute
lower respiratory illness (8-12), respiratory symptoms (13-16), prevalence and
severity of asthma (13,17,18), impaired lung function and bronchial
responsiveness (10,12,13,16,17,19-23) could be demonstrated.
In contrast to chronic exposure, little is known on the acute effect of passive
smoking in children. We therefore studied symptoms, lung function and
airway responsiveness of children with bronchial asthma before and after one
hour exposure to cigarette smoke as compared to control conditions.

j
Oldigs et aL: Acute effect of passive smoking....3
MATERIAL AND METHODS
Patients
We investigated 11 children with allergic bronchial asthma (10 boys, 1 girl)
ranging in age from 8 to 13 years (mean (SD) 10.4 (1.4) yr). Individual patient
characteristics are given in table 1.
In all children the diagnosis of bronchial asthma was made up within at least
1 year before entering the study and patients had been followed up for a
longer period of time on an out-patient basis.
Diagnosis was based on typical symptoms, reversible airflow obstruction,
bronchial hyperresponsiveness to histamine and a positive prick skin test to
at least one common allergen (Allergopharma, Reinbek, FRG). Six out of 11
patients showed an increase in total IgE (>150 IE/ml), and 6 children an
increase of eosinophils in peripheral blood (>300/mm3).
In- all subjects the severity of asthma required a long-term therapy, which had
to be continued in 9 of 11 children during the study period. All children on
therapy received disodium cromoglycate, two puffs two to four times per day.
Each puff of disodium cromoglycate (1 mg) was combined with 0.05 mg
fenoterol (DitecR) or 0.5 mg reproterol (AaraneR) as a Q2-agonist. One subject
took two additional puffs of 200 µg beclomethasone dipropionate. In all
children, this therapeutic regime was sufficient to control the disease and
allow normal activities. This is also reflected by the magnitude of morning
(before therapy, PEFr,,;n) and maximum daytime peak flow values (PEF,t,ax),
which were measured regulary (table 1).
In the 9 asthmatic children receiving regular therapy, the activity of the
disease allowed to discontinue inhalation therapy at least six hours prior to

Oldigs et al.: Acute effect of passive smoking....4
1
i
each study session without precipitating symptoms or deteriorating lung
function (subject 6 continued beclomethasone inhalation during the study
period).
Spirometry, measured at least six hours after inhaling a bronchodilator was
within normal limits. In all children the provocative concentration of
inhaled histamine necessary to decrease FEVt by 20% as compared to baseline
was less than 8 mg/ml (table 1), thus demonstrating airway hyperrespon-
siveness (see Histamine inhalation challenge).
During the study period and within the two weeks preceeding the study no
child suffered from an upper respiratory tract infection, experienced an
uncommon burden of allergen or reported on any other trigger which may
worsen asthma; therefore all included children were considered to be
currently clincallv stable.
None of the children had ever actively smoked cigarettes, six of them were
exposed to cigarette smoke at home (table 2).
Children and parents were informed about the aim of the study and gave
their consent.
Cigarette smoke exposure
Exposure chamber
The study was performed in a 24 m3 exposure chamber. To ensure
homogenous concentration of cigarette smoke the air was moved by fans in
a spiral form. Sampling ports were distributed within the chamber to check
for gradients of gas concentrations and partide density. Cigarette smoke was

I
Oldigs et aL: Acute effect of passive smoking....5
generated by a smoking machine designed in our laboratory which took 1
puff per cigarette per minute (according to DIN 10240). To achieve the target
concentration of about 20 ppm CO, on average 2 cigarettes were smoked
simultaneously. We used filter cigarettes of a leading brand with a nicotine
content of 0.9 mg and tar content of 13 mg per cigarette.
Measurement of exposure conditions
The level of cigarette smoke exposure was determined by measuring CO,
NO,, partide density, nicotine, acetaldehyde, formaldehyde, aaolein and
ammonia. Concentration of CO was measured continuously by an infrared
gas analyzer (Unor 6N, Maihak AG, Hamburg, FRG) whose calibration was
checked daily by a certified span gas (Linde AG, Unterschleii3heim, FRG).
Concentration of NO,, was measured by a chemiluminescence nitrogen
oxides analyzer (8840, Monitor Labs Inc., San Diego, CA, USA) which was
calibrated regularly by a permeation tube calibrator (Model 8550, Monitor
Labs Inc., San Diego, CA). Particle density was monitored continuously by
measuring optical particle density (RAM-l, GCA/Environmental
Instruments, Bedford, Mass., USA) using a 4 µm precollector. Calibration of
optical particle density was done in regular intervals gravimetrically by
taking filter probes (Millipore, FALP 03700, Typ FA) from total sampling
volumes of 17-73 litres of air. Nicotine, acetaldehyde, formaldehyde, aaolein
and ammonia were determined using commercially available sample tubes
and filters at sampling volumes ranging between 3 and 100 litres of air.
Analysis was done by gas chromatography (nicotine), by HPLC (acetaldehyde,
formaldehyde, acrolein) and by the indophenol method VDI 2461

i
I
Oldigs et al.: Acute effect of passive smoking....6
(ammonia). Temperature and relative humidity were measured at the
beginning and at the end of each exposure.
Estimation of chronic smoke exposure
To estimate chronic passive smoke exposure at home, urinary cotinine
concentrations were determined in triplicate from morning urine spedmens
collected at the second study day. Urine was stored at -20 OC until assayed.
Cotinine was measured by a radioimmunoassay procedure (24).
Assessment of symptoms
Before and immediately after exposure the chest of each subject was
auscultated by one of us (M.O.). To estimate severity of symptoms induced by
exposure, the children and their parents were instructed to check an ordinal
scale ranging from 0 to 10 in order to determine severity of eye, nose
irritation, throat irritation, cough, chest tightness and headache. Zero
indicated no perceptible symptom, 10 almost intolerable severity of the
respective symptom.
Lung Function Measumment
Airway resistance (Raw) during breathing at 1 Hz and thoracic gas volume
(TGV) were measured by a volume-constant body plethysmograph (Bodytest,
E. Jaeger, Wurzburg, FRG) connected to a Computer (PDP 11 /04, Digital

Oldigs et aL: Acute effect of passive smoking....7
I
Equipment Corp., Maynard, MA, USA). Airway resistance was multiplied by
the corresponding thoradc gas volume to obtain specific airway resistance
(SRaw). Airway resistance was measured during up to 4 breathing cycles. FEVI
was assessed by a pneumotachygraph immediately after body plethysmo-
graphy. Measurements were repeated 4 times. For analysis, the average of 4
values of SRaw and the average of the two maximum values of FEVI was
taken.
Histamine Inhalation Challenge
Bronchial challenge with histamine was done according to the guidelines of
Chai et al. ;25) using a breath-synchronized pressure valve. The aerosols were
generated during 0.6 sec. at the beginning of 5 slow inspirations from FRC to
TLC, the nebulizer output being 80 µl of solution per 5 nebulizations. Saline
solutions of histamine diphosphate (Sigma Chemie, Deisenhofen, FRG) were
prepared daily. After inhaling buffer solution, the subjects inhaled doubling
concentrations of histamine, starting with 0.05 mg/ml histamine. Lung
function was measured 1 and 3 min after inhalation. The inhalation was
stopped after at least a 100 % inaease of SRaw and a 20 % fall in FEVt. Dose-
response curves were constructed by plotting SRaw and FEVI against log
histamine concentration. By linear interpolation, the provocative
concentrations of histamine (in mg/ml) were computed necessary to increase
SRaw by 100 %(PC1opSRaw) and to decrease FEVI by 20 %(PC20FEV1) as
compared to baseline. With this method, hyperresponsiveness was assumed
if PC-values were below 8 mg/ml (26).

Oldigs et al.: Acute effect of passive smoking....8
i
Experimental Protocol
Each subject was studied at three days within a two week period. All
investigations were performed at least six hours after the last application of
therapy.
On the first day recent history was taken and a physical investigation
performed. Lung function and airway responsiveness to inhaled histamine
were measured. In case of stable clinical conditions, normal lung function and
airway hyperresponsiveness, the children and their.parents were instructed in
the experimental procedure. They were provided with sampling probes for
collecting morning urinary specimens.
On the second study day, exposure to ambient air (Sham) and at the third
study day exposure to cigarette smoke was performed.
On exposure days, subjects rested for 10 minutes after entering the laboratory.
After auscultation of the chest, assessment of svmptoms and measurement of
baseline lung function, the children entered the exposure chamber. They were
always seated at the same place inside the chamber. Five minutes before the
end of exposure, symptoms were assessed again. Immediately after exposure,
auscultation of the chest and lung function measurement were performed.
Histamine inhalation challenge was started 15 minutes after the end of
exposure.

Oldigs et aL: Acute effect of passive smoldng....9
i
Statistical Analysis
Lung function parameters before and after both exposures and control values
were compared to each other by the paired t-test after appropriate Bonferroni
correcrion for multiplicity of tests (27). Log PC-values after both exposures and
control values were also compared by the paired t-test. Statistical significance
was assumed for p<0.05.
RESULTS
Exposure conditions
During Sham and cigarette smoke exposure, mean (SD) temperature was 24.1
(1.6) oC and mean relative humidity was 51 (3) %, with no difference between
the study days. During passive smoke exposure, mean (SD) total particle
density was 2743 (348) µg/m3 and nicotine content was 397 (78) µg/m3. Mean
(SD) concentrations of CO were 20.5 (0.5) ppm, NO,, 0.90 (0.09) ppm,
formaldehyde 0.13 (0.01) ppm, acetaldehyde 0.50 (0.05) ppm, acrolein 0.081
(0.017) ppm and ammonia 5.69 (3.35) ppm. During exposure with ambient air,
mean (SD) CO was 0.1 (0.3) ppm, and mean (SD) total partide density was 17
(57) ug/m3.
Symptoms during exposure
In all of our children, auscultation of the chest was normal before and after
exposure to Sham and cigarette smoke, respectively. Eye irritation was
